Imipramine Tillomed (Imipramine Hydrochloride)

Imipramine Tillomed, a tricyclic antidepressant, is indicated for several psychiatric conditions.

• Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients.
• Depressive episodes associated with bipolar disorder: helps manage the depressive phase of bipolar illness.
• Panic disorder: reduces the frequency and severity of panic attacks.

• Imipramine Hydrochloride inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, thereby increasing their extracellular concentrations. The enhanced monoaminergic neurotransmission contributes to mood elevation and anxiolytic effects characteristic of tricyclic antidepressants.

Imipramine Tillomed may cause a range of adverse reactions, some of which are frequent while others are uncommon but serious.

Common Side Effects

• Dry mouth: reduced salivary secretion.
• Constipation: slowed gastrointestinal motility.
• Blurred vision: transient visual disturbances.
• Drowsiness: increased sedation.
• Weight gain: gradual increase in body weight.
• Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing heart disease.
• Seizures: heightened risk of convulsive episodes.
• Severe hypotension: marked drop in blood pressure on standing.
• Agranulocytosis: dangerously low white‑blood‑cell count.
• Hepatotoxicity: liver enzyme elevation or injury.
• Suicidal ideation: emergence or worsening of suicidal thoughts.

Before initiating therapy with Imipramine Tillomed, several safety considerations are recommended.

• Cardiovascular assessment: evaluate heart function, especially in patients with known cardiac disease.
• Suicidal monitoring: watch for emergence of suicidal thoughts, particularly early in treatment.
• Elderly caution: start at low dose and monitor for anticholinergic effects.
• Discontinuation: avoid abrupt cessation to reduce risk of withdrawal symptoms.
• Hepatic/renal function: adjust dosing if significant impairment is present.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Imipramine Tillomed can interact with several other medicines; the significance of each interaction varies.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: increased serotonin syndrome risk.
• Certain anticholinergic agents: additive anticholinergic burden.
• Drugs that prolong QT interval: heightened arrhythmia potential.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise imipramine plasma levels.
• Antihypertensive agents: possible additive blood‑pressure lowering effect.
• CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation.
• Anticholinergic drugs: monitor for excessive dry mouth and constipation.
• Herbal supplements (e.g., St. John’s wort): may alter drug metabolism.